<code id='43C9596B23'></code><style id='43C9596B23'></style>
    • <acronym id='43C9596B23'></acronym>
      <center id='43C9596B23'><center id='43C9596B23'><tfoot id='43C9596B23'></tfoot></center><abbr id='43C9596B23'><dir id='43C9596B23'><tfoot id='43C9596B23'></tfoot><noframes id='43C9596B23'>

    • <optgroup id='43C9596B23'><strike id='43C9596B23'><sup id='43C9596B23'></sup></strike><code id='43C9596B23'></code></optgroup>
        1. <b id='43C9596B23'><label id='43C9596B23'><select id='43C9596B23'><dt id='43C9596B23'><span id='43C9596B23'></span></dt></select></label></b><u id='43C9596B23'></u>
          <i id='43C9596B23'><strike id='43C9596B23'><tt id='43C9596B23'><pre id='43C9596B23'></pre></tt></strike></i>

          knowledge

          knowledge

          author:focus    Page View:627
          Brain cancer
          Michelle Monje/Stanford University/NIH

          Tocagen (TOCA) said Tuesday that a Phase 3 clinical trial involving a novel gene therapy for aggressive brain tumors will continue to a final analysis later this year, following an interim look at patient survival data conducted by independent monitors. Tocagen’s stock price dropped sharply.

          The San Diego-based biotech pitched the study’s continuation as an encouraging sign for its gene therapy called Toca 511/Toca FC, which is designed to deliver a localized chemotherapy directly to the site of brain tumors.

          advertisement

          “We believe the longer-term follow-up of patients in the final analysis, particularly for those randomized in the second enrollment period, will be important in assessing both primary and secondary endpoints,” said Tocagen CEO Marty Duvall, in a statement.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more
          New oral drug delivery patch is modeled after octopus tentacles
          New oral drug delivery patch is modeled after octopus tentacles

          AdobeThestoryofthelatestdevelopmentindrugadministrationtechnology—amouthpatchthatcandeliverpeptidesa

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          Flu, Covid vaccination rates decline, new survey data show

          JustinSullivan/GettyImagesVaccinationratesagainstfluandCovid-19havedeclinedsinceearlierinthepandemic